[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Your Free 7-Day Premier trial ends on . Extend Your Trial For Another 30 Days. Time remaining
Faster, Cleaner, Better.

Adial Pharmaceuticals Inc (ADIL)

Adial Pharmaceuticals Inc (ADIL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Adial Pharmaceuticals Inc 4870 SADLER ROAD SUITE 300 Glen Allen VA 23060 USA

www.adial.com Employees: 6 P: 804-487-8196

Sector:

Medical

Description:

Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focused on the development of a therapeutic agent for the treatment of alcohol use disorder. The company's lead product consists of AD04 which is in clinical stage. Adial Pharmaceuticals Inc. is based in CHARLOTTESVILLE.

Key Statistics

Overview:

Market Capitalization, $K 15,624
Enterprise Value, $K 9,744
Shares Outstanding, K 2,626
Float, K 2,416
% Float 92.00%
Short Interest, K 232
Short Float 8.81%
Days to Cover 2.72
Short Volume Ratio 0.88
% of Insider Shareholders 8.00%
% of Institutional Shareholders 16.41%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -7,980 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ 0 K
EBIT, $ -57,680 K
EBITDA, $ -57,680 K

Growth:

1-Year Return -36.93%
3-Year Return -93.28%
5-Year Return -99.77%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 97.81%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -11.25 on 08/14/26
Next Earnings Date 11/12/26
Earnings Per Share ttm -14.73
EPS Growth vs. Prev Qtr -660.14%
EPS Growth vs. Prev Year -150.00%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-25 on 02/06/26

ADIL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -203.87%
Return-on-Assets % -512.41%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -14.59
Interest Coverage -0.54
60-Month Beta 1.37
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.